Metraipolis › archive › dc_fb365d28e09e

Fixed-dose vs loose-dose combination antidiabetic therapy and cardiorenal outcomes in type 2 diabetes: a nationwide comparative effectiveness study — Europe PMC PMID:40988019

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40988019
DOI
10.1186/s12933-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-09T19:37:23.387Z
SHA-256 of the archived text
1a45e960d502a1ba095c20224162a894adea6e8af45d988fba13ee866fc25063
Stable URL of this page
https://metraipolis.com/documento/dc_fb365d28e09e

How to cite

Fixed-dose vs loose-dose combination antidiabetic therapy and cardiorenal outcomes in type 2 diabetes: a nationwide comparative effectiveness study — Europe PMC PMID:40988019 — Europe PMC (en), https://europepmc.org/article/MED/40988019 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb365d28e09e (Metraipolis archive dc_fb365d28e09e, sha256 1a45e960d502a1ba095c20224162a894adea6e8af45d988fba13ee866fc25063)
BibTeX
@misc{dcfb365d28e09e,
  title = {Fixed-dose vs loose-dose combination antidiabetic therapy and cardiorenal outcomes in type 2 diabetes: a nationwide comparative effectiveness study — Europe PMC PMID:40988019},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40988019},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb365d28e09e; sha256 1a45e960d502a1ba095c20224162a894adea6e8af45d988fba13ee866fc25063},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40988019. Agents can read the archived copy with the MCP tool read_document.